|
Status |
Public on Oct 31, 2017 |
Title |
1001_1001_0BM |
Sample type |
genomic |
|
|
Source name |
genomic DNA from pediatric AML
|
Organism |
Homo sapiens |
Characteristics |
diagnosis: Acute Myelogenous Leukemia tissue: bone marrow aspirate tissue type: diagnostic marrow
|
Treatment protocol |
NA
|
Growth protocol |
NA
|
Extracted molecule |
genomic DNA |
Extraction protocol |
All Prep DNA/RNA extraction kit (Qiagen)
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina protocol
|
|
|
Hybridization protocol |
Standard Illumina protocol
|
Scan protocol |
Illumina HiScan
|
Description |
ARM B
|
Data processing |
GenomeStudio V2011.1
|
|
|
Submission date |
Mar 07, 2016 |
Last update date |
Oct 31, 2017 |
Contact name |
Bodour Salhia |
E-mail(s) |
bsalhia@tgen.org
|
Organization name |
Translational Genomics Research Institute
|
Department |
Integrated Cancer Genomics Division
|
Street address |
445 N Fifth Street
|
City |
Phoenix |
State/province |
AZ |
ZIP/Postal code |
85004 |
Country |
USA |
|
|
Platform ID |
GPL13534 |
Series (1) |
GSE78963 |
A Multicenter, First-in-Pediatrics, Randomized Study to Evaluate the Safety and Efficacy of Decitabine as Epigenetic Priming with Induction Chemotherapy in Children with Acute Myelogenous Leukemia |
|